A chromosomal deletion of the major tumor-suppressor center 1p36-35, in which RUNX3 is epigenetically inactivated, is frequently present in diverse cancer types, including 20% to 40% of cases of patients with neuroblastoma [79]. This evidence concerns the gene RUNX3 and cancer.